Pacific Diabetes Technologies
Solar-powered, waterless, autonomous GPU data centers in modular pod form
- Sector
- Medtech
- Headquarters
- Portland, OR
- Founded
- 2021
- Latest Form D
- $2.9M, Oct 2025
- Total capital
- $8.1M
- Federal grants
- $2.6M
- 4 awards · 2016–2022
- Rank in peer group#435 of 538
- Private capital raised
- $5.5M
- 4 Form D · last Oct 2025
- 12 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 7
- 20 pending · first 2020
- Rank in peer group#86 of 538
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 4th filing$2.9M
- Private capital raisedForm D · SEC · 3rd filing$2.1M
- Private capital raisedForm D · SEC · 2nd filing$500K
- Federal grantHealth and Human S · Phase II · Development of a miniaturized single-port automated insulin delivery system utilizing a glucose sensing catheter, ultra-concentrated insulin, and an optimized control algorithm$552K
- Federal grantHealth and Human S · Phase II · Development of a miniaturized single-port automated insulin delivery system utilizing a glucose sensing catheter, ultra-concentrated insulin, and an optimized control algorithm$1.5M
- Offering registeredForm D · SEC · 1st filing$2M
- Federal grantHealth and Human S · Phase I · Development of a miniaturized, single-port automated insulin delivery system utilizing a glucose sensing catheter, ultra-concentrated insulin, and an optimized control algorithm$300K
Show 1 earlier federal award
- Federal grantHealth and Human S · Phase I · Avoidance of Interference from Insulin Preservatives in a Dual-use Catheter for T1D$224K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
58months
from Pacific Diabetes Technologies’s first federal award to its first private round.
- First federal award · Aug 2016
- Health and Human S · $224K
- First Form D · Jun 2021
- $2M · 1st Form D
- Awards before first raise
- 2 awards
An association in public records, not a cause or a prediction.
Standing among 538 peers
Line = medianMedtech · Device
- Federal grantsBelow median
- Granted patents#86 · top 16%
- Linked publications#80 · top 15%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Thomas SeidlResearcherExecutive Officer, DirectorLinked by 1 patent · $1.5M in grants as PI
- Christopher MarshDirectorNamed in SEC Form D filings
- Ed La CavaDirectorNamed in SEC Form D filings
- Edward La CavaDirectorNamed in SEC Form D filings
- Hank WuhDirectorNamed in SEC Form D filings
- Kenneth WardDirectorNamed in SEC Form D filings
Show all 11 people
- Ken WardDirectorNamed in SEC Form D filings
- Mark HuberDirectorNamed in SEC Form D filings
- Peter EckenbergDirectorNamed in SEC Form D filings
- Thomas SeidelExecutive Officer, DirectorNamed in SEC Form D filings
- Yobie BenjaminDirectorNamed in SEC Form D filings
What it has protected
USPTO · 7 granted of 27- PendingMeasurement Of Glucose Near An Insulin Delivery Catheter By Minimizing The Adverse Effects Of Insulin Preservatives: Alternative Ligands And Redox Mediator MetalsUSPTOApplication 19393204
- GrantedMethods And Systems For Insulin Delivery And Glucose MeasurementUSPTOUS 12,611,504
- PendingSelf-inserting Trocarless Analyte-sensing CannulaUSPTOApplication 19268419
Show all 27 patent records
- Measurement Of Glucose Near An Insulin Delivery Catheter By Minimizing The Adverse Effects Of Insulin Preservatives: Alternative Ligands And Redox Mediator MetalsMay 21, 2026 · Application 19393204Pending
- Methods And Systems For Insulin Delivery And Glucose MeasurementApr 28, 2026 · US 12,611,504Granted
- Self-inserting Trocarless Analyte-sensing CannulaJan 1, 2026 · Application 19268419Pending
- Measurement Of Glucose Near An Insulin Delivery Catheter By Minimizing The Adverse Effects Of Insulin Preservatives: Alternative Ligands And Redox Mediator MetalsDec 16, 2025 · US 12,495,995Granted
- Methods And Systems For Insulin Delivery And Glucose MeasurementNov 25, 2025 · US 12,478,734Granted
- Methods And Systems For Insulin Delivery And Glucose MeasurementAug 12, 2025 · US 12,383,675Granted
- Biosensors and Methods for Determining Analyte Concentration in the Kinetic Potential Region of Redox Mediators with Single-Point CalibrationJul 17, 2025 · Application 19012059Pending
- Biosensors and Methods for Determining Analyte Concentration in the Kinetic Potential Region of Redox MediatorsFeb 4, 2025 · US 12,216,074Granted
- Long-lived Insulin Delivery CannulaFeb 1, 2024 · Application 18212477Pending
- Pump-connectable Analyte Sensing CannulaFeb 1, 2024 · Application 18227071Pending
- Drug Delivery Cannula with Continuous Glucose Monitoring CapabilityOct 12, 2023 · Application 18132589Pending
- Signal Processing Algorithm For Improving Accuracy Of A Continuous Glucose Sensor And A Combined Continuous Glucose Sensor And Insulin Delivery CannulaDec 8, 2022 · Application 17684015Pending
- Wired Continuous Glucose Monitoring Infusion SetNov 3, 2022 · Application 17730745Pending
- Systems And Methods For Blood Glucose Management Using Concentrated InsulinNov 3, 2022 · Application 17730741Pending
- Infusion Device For Continuous Glucose MonitoringAug 25, 2022 · Application 17549232Pending
- Measurement Of Glucose In An Insulin Delivery Catheter By Minimizing The Adverse Effects Of Insulin PreservativesMar 17, 2022 · Application 17410866Pending
- Measurement Of Glucose In An Insulin Delivery Catheter By Minimizing The Adverse Effects Of Insulin PreservativesOct 5, 2021 · US 11,135,369Granted
- Measurement of Glucose in an Insulin Delivery Catheter by Minimizing the Adverse Effects of Insulin PreservativesSep 22, 2020 · US 10,780,222Granted
- Dual-use Catheter for Continuous Analyte Measurement and Drug DeliveryOct 2, 2014 · Application 14304166Pending
- Measurement Of Glucose Near An Insulin Delivery Catheter By Minimizing The Adverse Effects Of Insulin Preservatives: Alternative Ligands And Redox Mediator MetalsApplication 63069088Pending
- Infusion Device For Continuous Glucose MonitoringApplication PCTUS2020037511Pending
- Infusion Device with Continuous Glucose Monitoring CapabilityApplication 62861940Pending
- Measurement Of Glucose Near An Insulin Delivery Catheter By Minimizing The Adverse Effects Of Insulin Preservatives: Alternative Ligands And Redox Mediator MetalsApplication PCTUS2021046894Pending
- Pump-connectable Analyte Sensing CannulaApplication PCTUS2022014116Pending
- Long-lived Insulin Delivery CannulaApplication PCTUS2021064448Pending
- Drug Delivery Cannula With Continuous Glucose MonitoringApplication PCTUS2021054956Pending
- Self-inserting Trocarless Analyte-sensing CannulaApplication PCTUS2024011596Pending
Recent research by its founders
- First in Human Feasibility Study of an Insulin Patch Pump Combined With CGM-Insulin Delivery Cannula20260 cites
- Feasibility study of a combined insulin‐delivery and glucose sensor system worn over 7 days in persons with type 1 diabetes20251 cites
- 156-OR: Single-Device Glucose Sensing and Insulin Delivery—Patient-Reported Outcomes20250 cites
Related companies, and why
- Qidni Labs Inc.Similar federal contract value in Medtech · null in contracts
- Nexsis Biosciences LLCSimilar federal contract value in Medtech · null in contracts
- Imagin Medical Inc.Similar federal contract value in Medtech · null in contracts
- FLOREO, INC.Similar federal contract value in Medtech · null in contracts
- EndoSound, Inc.Similar federal contract value in Medtech · null in contracts
- APPLIKATE TECHNOLOGIES, INC.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .